A randomized double blind placebo controlled parallel group efficacy and sagety study of oral administration of empagliflozin twice daily versus once daily in two different daily doses over 16 weeks

  • Simpson, Richard (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/10/12 → 13/11/13